Resultados de la búsqueda 61-70 of 11221 for Acute alcohol intoxication

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    To evaluate the safety and efficacy of Siegel™ TAVR System in the treatment of subjects with symptomatic severe native aortic stenosis. BoxX-NoAF Clinical Trial.

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    The hypothesis is that the early surgery group will have a significantly lower all-cause mortality and incidence of acute aortic events at 2 years of follow up ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    ... toxicity. Patient demographics, adverse events ... The Effects Of Acute And Chronic Exercise On ... This clinical trial studies the effect of short-term (acute) ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    This clinical trial studies the effect of short-term (acute) and long-term (chronic) exercise on immune characteristics and function (phenotype) of patients ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B ...

  6. Presión arterial alta (hipertensión)

    Alcohol and your health. National Institute on Alcohol Abuse and Alcoholism. https://www.rethinkingdrinking.niaaa.nih.gov/Default.aspx. Accessed July 18 ...

  7. Médicos y departamentos

    https://www.merckmanuals.com/professional/injuries-poisoning/burns/burns. ... Acute assessment and management of burn injuries. ... https://www.merckmanuals.com/ ...

  8. Mayo Clinic Pulmonology Physician Update - December 2024

    Page 1.

  9. Deficiencia de alfa-1 antitripsina

    Alcohol consumption and liver phenotype of individuals with alpha-1 antitrypsin deficiency. Liver International. 2024; doi:10.1111/liv.16044. Brown RS Jr ...

  10. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    A standard treatment is considered not well tolerated if the patient experiences severe side effects without providing an acceptable level of clinical benefit.